Latigo Biotherapeutics Inc. (LTGO)
$22.37+4.53%Close
FLAT
Key stats
- Market cap
- $1.3B
- Avg volume
- 509.9K
- Beta
- 0.00
- 1W
- +14.78%
- YTD
- +22.58%
- vs SPY 1W
- +16.14%
- vs SPY YTD
- +10.49%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- SEERSELLSeer, Inc.RECOVERYQ -22$2.03+0.50%
- TLSABUYTiziana Life Sciences LtdRECOVERYQ 1$1.14+1.79%
- PHIOBUYPhio Pharmaceuticals Corp.RECOVERYQ 3$1.18-2.48%
- INABBUYIN8bio, Inc.RECOVERYQ -20$1.28+5.79%
- KYNBBUYKyntra Bio, Inc.RECOVERYQ -15$7.52+2.73%
- GOVXBUYGeoVax Labs, Inc.CRISISQ -19$0.65+8.33%
- ANTXBUYAN2 Therapeutics, Inc.RECOVERYQ -7$5.81+0.35%
- ENTABUYEnanta Pharmaceuticals, Inc.RECOVERYQ 13$13.47+2.59%
- PLSEBUYPulse Biosciences, Inc.BULLQ 26$50.42+5.37%
- VNRXSELLVolitionRx LimitedCRISISQ -10$0.42-4.55%
- ZCMDBUYZhongchao Inc.CRISISQ -39$0.93-3.12%
- ODTXBUYOdyssey Therapeutics, Inc.Q 80$26.39+6.97%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-
---
[VALUATION]
P/E TTM-
P/E FWD-
SECTOR PE22.60
INDUSTRY PE157.47
P/B-
P/FCF-
EV/EBITDA-
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO-
ND/EBITDA-
BETA0.00
NET INCOME (TTM) < 0
